1. Factors that may influence the choice for initiating apremilast or methotrexate treatment for psoriasis in real‐world clinical setting. (30th July 2019) Authors: Fougerousse, A.‐C.; Maccari, F.; Beauchet, A.; Parier, J.; Boulard, C.; Becherel, P.‐A.; Quiles‐Tsimaratos, N.; Le Guyadec, T.; Thomas‐Beaulieu, D.; Halioua, B.; Begon, E.; Bastien, M.; Perrot, J.‐L.; Pallure, V.; Bilan, P.; Steff, M.; Pfister, P.; Vermersch‐Langlin, A.; Boyé, T.; Mery‐Bossard, L. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 33:Number 12(2019) Page Start: e476 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗